Show side menu

Immunological characterization of adjuvants, probiotics and immunomodulators

Technological offer upon request serving private businesses and public institutions interested in testing the immunological responses induced by adjuvant, probiotics or any other compound with immunomodulator properties.


  • Scientific consulting leading the most appropriate experimental design, adapted to the biological nature of the compound to be tested and to the intended applications.
  • In vitro and in vivo characterization of the innate and adaptive immune response, induced; using as targets small and large animal models
  • In vivo characterization of the adaptive immune response induced (antibody and T-cell responses) by the given product alone or in combination with experimental or commercial vaccines.
  • Efficacy studies in experimental animals and in the field.
  • Design and development of new immunological tools such as specie-specific polyclonal or monoclonal antibodies.



  • Studies can be performed using many different animal species.
  • Multidisciplinary team of researchers: from the basics to the field.
  • BSL3 infrastructures: controlled containment facilities.



  • Proof of concept and validation of candidates for novel immunomodulatory.
  • Development of new immunological tools.
  • Know how transfer.
  • Collaborating as a Contract Research Organization (CRO) or for research projects.

Examples of previous achievements

  • Characterization of the immunomodulatory properties of diverse adjuvant and probiotic molecules in different animal species.
  • Characterization of dendritic cell populations in pigs.
  • Interaction of porcine dendritic cells with different bacteria and viruses.
  • Effects of immunomodulatory molecules in vaccination and infection.


Download all the services at IRTA-CReSA (PDF)

Revisa aquest camp

Revisa aquest camp

Revisa aquest camp

Your message has been sent succesfully
Unable to send, try again